In silico designing and expression of novel recombinant construct containing the variable part of CD44 extracellular domain for prediagnostic breast cancer

BACKGROUND: CD44, as a tumor‐associated marker, can be used to detect stem cells in breast cancer. While CD44 is expressed in normal epithelial cells, carcinoma cells overexpress CD44. AIMS: In the current study, we designed a recombinant protein that included the variable component of the CD44 (CD4...

Descripción completa

Detalles Bibliográficos
Autores principales: Gheybi, Elaheh, Asoodeh, Ahmad, Amani, Jafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026285/
https://www.ncbi.nlm.nih.gov/pubmed/36289579
http://dx.doi.org/10.1002/cnr2.1745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10026285/
https://www.ncbi.nlm.nih.gov/pubmed/36289579
http://dx.doi.org/10.1002/cnr2.1745

Ejemplares similares